Creative Medical Technology Holdings Inc (CELZ)

[uvaphd]

Bear in mind (1) that the vast majority of their clinical trial subjects were UNRESPONSIVE to pills (estimated at around 9M men in the US alone) and (2) we achieve statistical significance with a positive correlation of two factors at around 60%. Obviously there is no 100%-effective solution for everybody (we just talked about 9M people), but it should be noted that the clinical patients were “the toughest of the challenged”—one naturally wonders what the CaverStem efficacy percentage would be among the less challenging (more responsive) millions of men...